LEVODOPA AND L-TRYPTOPHAN THERAPY IN PARKINSONISM
- 25 March 1972
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 299 (7752) , 654-658
- https://doi.org/10.1016/s0140-6736(72)90461-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- MENTAL SYMPTOMS IN PARKINSONIAN PATIENTS TREATED WITH L-DOPAThe Lancet, 1970
- Treatment of Parkinsonism with Laevo-DopaBMJ, 1970
- 5-HYDROXYTRYPTAMINE, NORADRENALINE, AND DOPAMINE IN BRAINSTEM, HYPOTHALAMUS, AND CAUDATE NUCLEUS OF CONTROLS AND OF PATIENTS COMMITTING SUICIDE BY COAL-GAS POISONINGThe Lancet, 1969
- L-DOPA IN POSTENCEPHALITIC PARKINSONISMThe Lancet, 1969
- Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylaseJournal of Pharmacy and Pharmacology, 1968
- Development of a Rating Scale for Primary Depressive IllnessBritish Journal of Social and Clinical Psychology, 1967
- On the Occurrence of Homovanillic Acid and 5-Hydroxyindol-3-ylacetic Acid in the Ventricular C.S.F. of Patients Suffering from ParkinsonismStereotactic and Functional Neurosurgery, 1967
- Zur Biochemie des Parkinson-Syndroms des MenschenKlinische Wochenschrift, 1963
- Der L-Dioxyphenylalanin (=L-DOPA)-Effekt beim Parkinson-Syndrom des Menschen: Zur Pathogenese und Behandlung der Parkinson-AkineseArchiv Fur Psychiatrie Und Nervenkrankheiten, 1962
- Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsJournal of Molecular Medicine, 1960